Difference between revisions of "Part:BBa I714891:Experience"

(Applications of BBa_I714891)
 
(4 intermediate revisions by 2 users not shown)
Line 12: Line 12:
 
[[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771113 BBa_K771113]]
 
[[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771113 BBa_K771113]]
 
[[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771114 BBA_K771114]]
 
[[https://parts.igem.org/wiki/index.php?title=Part:BBa_K771114 BBA_K771114]]
 +
 +
[http://2018.igem.org/Team:AFCM-Egypt# Team:AFCM-Egypt 2018] provided specific characterization for this part by using eGFP for experimental characterization of lentiviral transfer plasmid transfection efficacy and apoptotic effect on colorectal cancer cell line RKO.
  
 
===User Reviews===
 
===User Reviews===
 +
 +
 +
===edit by sysu-medicine===
 +
We validated this part by insert it and CMV promoter together into the vertor. The map of the plasmid is as followed(Fig.1). Then we transfected the plasmid to 293T cells, the expression of eGFP protein was observed by fluorescence microscope(Fig.2) and quantified by Image J(Fig.3). You can also see the characterization of this part in our composite part BBa_K2942705, BBa_K2942706, BBa_K2942707, BBa_K2942708.
 +
 +
 +
[[file:lyt911.jpg|720px]]
 +
 +
Fig.1 The plasmid we used for transfection.
 +
 +
 +
[[file:lyt912.jpg|720px]]
 +
 +
Fig.2 Transfection cells observed under a fluorescence microscope.
 +
 +
 +
[[file:lyt913.jpg|720px]]
 +
 +
Fig.3 Fluorescent quantitation by Image J(P<0.001).
 +
 
<!-- DON'T DELETE --><partinfo>BBa_I714891 StartReviews</partinfo>
 
<!-- DON'T DELETE --><partinfo>BBa_I714891 StartReviews</partinfo>
  

Latest revision as of 17:53, 21 October 2019

This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Applications of BBa_I714891

http://2012.igem.org/Team:SJTU-BioX-Shanghai 2012 SJTU-BioX-Shanghai team conducted split EGFP assay which could readily help visualize protein interaction. [BBa_K771113] [BBA_K771114]

[http://2018.igem.org/Team:AFCM-Egypt# Team:AFCM-Egypt 2018] provided specific characterization for this part by using eGFP for experimental characterization of lentiviral transfer plasmid transfection efficacy and apoptotic effect on colorectal cancer cell line RKO.

User Reviews

edit by sysu-medicine

We validated this part by insert it and CMV promoter together into the vertor. The map of the plasmid is as followed(Fig.1). Then we transfected the plasmid to 293T cells, the expression of eGFP protein was observed by fluorescence microscope(Fig.2) and quantified by Image J(Fig.3). You can also see the characterization of this part in our composite part BBa_K2942705, BBa_K2942706, BBa_K2942707, BBa_K2942708.


Lyt911.jpg

Fig.1 The plasmid we used for transfection.


Lyt912.jpg

Fig.2 Transfection cells observed under a fluorescence microscope.


Lyt913.jpg

Fig.3 Fluorescent quantitation by Image J(P<0.001).

UNIQ6f2f30a32c035fbf-partinfo-00000001-QINU

BBa_I714891 Tsinghua-D

This part works well for providing eGFP in high expression. We improve this part by adding a sequence of RNAT in from the eGFP gene. Thus, the expression of the reporter gene can be regulated by sensing the temperature.

;

UNIQ6f2f30a32c035fbf-partinfo-00000003-QINU